Noile-Immune Biotech Inc. (TYO:4893)
Japan flag Japan · Delayed Price · Currency is JPY
77.00
-4.00 (-4.94%)
Nov 18, 2026, 11:21 AM JST

Noile-Immune Biotech Balance Sheet

Millions JPY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,3333,9184,6705,5554,5204,140
Cash & Short-Term Investments
3,3333,9184,6705,5554,5204,140
Cash Growth
-19.06%-16.10%-15.93%22.90%9.18%62.48%
Other Receivables
13266266-53
Receivables
13266266-53
Inventory
2282034
Prepaid Expenses
242129382725
Other Current Assets
4916638343
Total Current Assets
3,4213,9834,7755,7174,5844,225
Long-Term Investments
262824615645
Other Long-Term Assets
1-1-11
Total Assets
3,4484,0114,8005,7784,6414,271

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
---1--
Accrued Expenses
203127294520
Current Income Taxes Payable
3139324823551
Other Current Liabilities
54108559
Total Current Liabilities
5674698633580
Other Long-Term Liabilities
667676
Total Liabilities
6280769234286

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
4,0544,0474,0474,0452,7872,537
Additional Paid-In Capital
4,0324,0254,0254,0232,7652,515
Retained Earnings
-4,706-4,147-3,353-2,389-1,259-872
Comprehensive Income & Other
665765
Shareholders' Equity
3,3863,9314,7245,6864,2994,185
Total Liabilities & Equity
3,4484,0114,8005,7784,6414,271

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
3,3333,9184,6705,5554,5204,140
Net Cash Growth
-19.06%-16.10%-15.93%22.90%9.18%62.48%
Net Cash Per Share
76.9190.48107.86133.96115.40108.06
Filing Date Shares Outstanding
43.443.343.343.339.5838.31
Total Common Shares Outstanding
43.443.343.343.339.5838.31
Working Capital
3,3653,9094,7065,6314,2494,145
Book Value Per Share
78.0290.78109.09131.33108.60109.23
Tangible Book Value
3,3863,9314,7245,6864,2994,185
Tangible Book Value Per Share
78.0290.78109.09131.33108.60109.23